1376 results

• Marketing Claims Over Lack of Blood Monitoring with Xarelto to be Issue in All Lawsuits: Lawyers

  November 11, 2014

  Irvin Jackson

  Xarelto litigation may rely heavily on claims manufacturers made regarding whether blood testing was necessary to administer the drug safely.

• Drug Companies Spend More On Marketing Than Research: Report

  November 10, 2014

  Irvin Jackson

  Most drug companies spend more on marketing than they do on drug research, according to a new report.

• FDA Failure to Ban Morcellators Amid Cancer Risk Draws Sharp Criticism

  November 7, 2014

  Irvin Jackson

  Advocates who have been calling for power morcellator bans are criticizing the FDA's apparent decision to keep the devices on the market, despite cancer risks.

• DePuy ASR Hip Patients Not Yet Requiring Revision Surgery Offered Tolling Agreement

  November 7, 2014

  Austin Kirk

  Plaintiffs pursuing DePuy ASR hip lawsuits who have not yet required revision surgery are being asked to elect how they intend to proceed with their claim.

• Talcum Powder May Cause Mesothelioma in Women: Study

  November 6, 2014

  Irvin Jackson

  The findings of a new study suggest that talcum powder can release asbestos fibers, which can cause mesothelioma lung cancer.

• Xarelto Lawsuit MDL Consolidation Opposed By Drug Manufacturers

  November 3, 2014

  Austin Kirk

  The makers of Xarelto are opposing a request to centralize all bleeding and wrongful death lawsuits before one judge.

• More DePuy ASR Cases May Settle As Recalled Hips Continue to Fail: Report

  November 3, 2014

  Irvin Jackson

  A new possible DePuy ASR settlement highlights how artificial hip makers may face product liability claims for years as their devices fall short of their projected lifespans

• Morcellation Risks Highlighted by Woman’s Death from Leiomyosarcoma

  October 30, 2014

  Irvin Jackson

  The plaintiff in one of the earliest power morcellator cancer lawsuits has died, highlighting the rapid consequences of spreading leiomyosarcoma.

• Johnson & Johnson Metal Hip Lawsuit Results in Defense Verdict

  October 24, 2014

  Irvin Jackson

  A Texas jury has returned a defense verdict in the first DePuy Pinnacle hip bellwether trial.

• U.K. Health Advisors Recommend Expanded Xarelto Use, Despite Bleeding Risks

  October 24, 2014

  Irvin Jackson

  U.K. regulators are set to approve Xarelto for use in recent heart attack patients, which FDA health experts have deemed as too risky a use for the drug in the U.S.